Skip to search formSkip to main contentSkip to account menu

enprofylline

Known as: 3-Propylxanthine, Enprofyllinum, Enprofilina 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Enprofylline (3-propylxanthine), a novel bronchodilating xanthine derivative that seems to lack adenosine antagonistic potency… 
2009
2009
The cardiovascular effects with bronchodilating plasma concentration of theophylline (3.8-12.6 mg/l) and enprofylline (0.8-3.0 mg… 
1996
1996
The physiological properties of adenosine may be essential in the control of energy metabolism for the survival of animals… 
1992
1992
The mechanism of action of xanthines in asthma remains controversial. Since sensory innervation may play a role in the… 
1988
1988
We compared the bronchodilating effects of intravenously administered enprofylline (2 mg/kg) with nebulized terbutaline (10 mg… 
1987
1987
Five different doses of enprofylline, a 3-propylxanthine, were compared with a standard dose of theophylline in 135 episodes of… 
1986
1986
The cardiovascular effects of enprofylline (with no adenosine receptor antagonism) and of theophylline (with adenosine receptor… 
1984
1984
Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability. It is eliminated almost exclusively… 
1984
1984
Twenty-five asthmatic outpatients were treated for 3 one-week periods with either enprofylline slowly eroding 300 mg tablets t.i… 
Highly Cited
1982
Highly Cited
1982
Theophylline, that is a potent adenosine receptor antagonist, and enprofylline (3-propylxanthine), that seems to lack antagonism…